The Current State of CUD Treatment
Here is the honest picture: as of 2025, no medication is FDA-approved for treating cannabis use disorder. A 2025 Cochrane systematic review found that THC analogs, cannabidiol, gabapentin, N-acetylcysteine, and antidepressants all provided inconsistent benefit. This is an active area of research, but pharmaceutical solutions are not yet reliable.
The good news — and it is genuinely good news — is that psychological treatments work. Multiple systematic reviews and randomized controlled trials support their effectiveness. The best-studied approaches carry evidence level Ia, the highest level of clinical evidence available. That means they are backed by multiple high-quality randomized controlled trials and meta-analyses.
Strong EvidenceIf you are considering treatment, the evidence is clear: therapy helps. You do not need to wait for a perfect medication. Effective help is available now.
Cognitive Behavioral Therapy (CBT)
Strong EvidenceCBT is the most extensively studied and consistently supported treatment for CUD. It focuses on identifying the external triggers and internal thought patterns that drive cannabis use, then building healthier alternatives.
How CBT Works in Practice
- Identifying triggers. Learning to recognize the situations, emotions, people, and environments that prompt you to use. A trigger might be boredom, social anxiety, coming home from work, or being around certain friends.
- Challenging automatic thoughts. Many people with CUD have deeply ingrained beliefs like "I can't relax without cannabis" or "I can't handle stress without smoking." CBT helps you examine these thoughts, test whether they are actually true, and develop more accurate alternatives.
- Building coping skills. Developing practical strategies for managing cravings, stress, negative emotions, and social pressure without cannabis.
- Behavioral activation. Replacing cannabis-related activities with engaging alternatives — finding activities that provide genuine satisfaction and reward.
- Relapse prevention. Learning to recognize warning signs, planning for high-risk situations, and understanding that a slip is not the same as total failure.
The Evidence for CBT
The CANDIS Study: One of the best-evaluated treatment protocols for CUD, the German CANDIS study combined CBT with motivational enhancement therapy and problem-solving training. In a sample of 279 patients, participants showed significantly more negative drug screenings and a major reduction in substance use with a Cohen's d of -0.9 — a large effect size. To put that in context, a Cohen's d of 0.8 is considered a "large" effect in psychology research. This treatment clearly works.
The Marijuana Treatment Project: The largest adult CUD treatment study to date, involving 450 participants. Nine sessions of combined CBT, motivational enhancement, and case management produced significant reductions in cannabis use and dependence symptoms.
The CANDIS study (279 patients) demonstrated a Cohen's d of -0.9 for reduction in cannabis use — a large effect size indicating clinically significant improvement.
PMC, "Evidence-based Treatment Options in Cannabis Dependency" (2016)
Motivational Enhancement Therapy (MET)
Strong EvidenceMET is designed for people who may not be fully sure they want to quit. It is nonjudgmental and patient-centered, which makes it particularly effective for people who are still weighing their options — and that is most people, at least at the beginning.
How MET Works
- A therapist provides personalized feedback about your cannabis use and its effects on your life
- You explore your own reasons for wanting to change — and your reasons for not wanting to
- Goal-setting is collaborative, not imposed from the outside
- The emphasis is on building self-efficacy — your belief in your own ability to change
The Evidence for MET
A randomized controlled trial of 188 participants found that MET was associated with fewer dependence symptoms and less cannabis use at 1-year follow-up. Because MET typically involves only 1 to 2 sessions, it can be more accessible and cost-effective than longer treatment programs — an important consideration for anyone facing financial barriers to care.
An RCT of 188 participants found that MET was associated with fewer dependence symptoms and less cannabis use at 1-year follow-up, with as few as 1-2 sessions.
PMC, "Treatment of Cannabis Use Disorder: Current Science and Future Outlook" (2016)
Combined CBT + MET: The Gold Standard
Strong EvidenceThe combination of CBT and MET is currently considered the best-evaluated treatment approach for adults with CUD. The combination makes intuitive sense: MET helps you find and strengthen your motivation to change, while CBT gives you the practical tools to actually do it.
Adding contingency management (CM) — which provides tangible rewards for meeting treatment goals like clean drug screenings — can further improve outcomes. However, research suggests that any psychosocial treatment is better than no treatment. The perfect should not be the enemy of the good. Access to any evidence-based therapy is what matters most.
Dialectical Behavior Therapy (DBT)
Moderate EvidenceDBT is especially effective for people who struggle with emotional dysregulation — intense emotions that feel overwhelming and difficult to manage. If you find that cannabis has become your primary tool for handling difficult feelings, DBT may be particularly relevant for you.
DBT teaches four core skill sets:
- Mindfulness: Being present with your experience without reacting automatically
- Distress tolerance: Getting through difficult moments without making things worse
- Emotion regulation: Understanding and managing intense emotions
- Interpersonal effectiveness: Maintaining relationships and self-respect while asking for what you need
While less studied specifically for CUD than CBT, DBT has proven effective for substance use disorders broadly, particularly in people with co-occurring emotional difficulties.
Contingency Management
Moderate EvidenceContingency management provides tangible incentives — small rewards, vouchers, or privileges — for meeting treatment goals such as attending sessions or providing negative drug screenings. It works by reinforcing the positive behavior of abstinence with immediate, concrete rewards, which can help bridge the gap during the early period when the natural rewards of sobriety have not yet become apparent.
When combined with CBT and MET, contingency management can improve treatment outcomes further.
Medications Under Investigation
Limited EvidenceWhile no medication is currently approved for CUD, several are being actively studied. None of these should be used for CUD without medical supervision, but they represent promising directions:
| Medication | Mechanism | Current Evidence |
|---|---|---|
| Gabapentin | Anti-seizure medication that modulates GABA | Weak but positive effect on reducing cannabis use and withdrawal symptoms in some trials |
| N-Acetylcysteine (NAC) | Amino acid supplement that modulates glutamate | Showed promise in adolescents initially; mixed results in subsequent studies |
| Cannabidiol (CBD) | Non-intoxicating cannabinoid | Under investigation for withdrawal and cravings; a study is evaluating 100mg CBD combined with CBT |
| Dronabinol | Synthetic THC (cannabinoid replacement) | Some promise for reducing withdrawal severity; not shown to improve long-term abstinence |
| Nabilone | Synthetic cannabinoid analog | Similar to dronabinol; may help with withdrawal but not long-term outcomes |
| Nabiximols (Sativex) | THC+CBD combination spray | Being studied as cannabinoid replacement therapy, similar to nicotine patches for smokers |
The cannabinoid replacement approach — using controlled doses of THC analogs to ease withdrawal, similar to how nicotine patches help smokers quit — is a particularly active area of research. Results so far are mixed: these medications may help with the acute discomfort of withdrawal but have not yet demonstrated improved long-term abstinence.
A 2025 Cochrane systematic review found that pharmacological interventions for CUD provided inconsistent benefit. Psychological treatments remain the primary evidence-based approach.
PMC, "Interventions for cannabis use disorder" (2021)
Finding Treatment
If you are ready to explore professional treatment, these resources can help you get started:
- SAMHSA Treatment Locator: findtreatment.gov — free, confidential tool for finding treatment facilities near you
- Psychology Today Therapist Finder: psychologytoday.com/us/therapists — filter by "substance use" specialty
- Cannabis Evidence: cannabisevidence.org — clinician-focused treatment briefs
- Our Finding a Therapist page has more guidance on choosing the right provider
The bottom line: Effective treatments for CUD exist right now. They are well-studied, they work, and they are available. You do not need to figure this out alone.
Sources and Further Reading
- PMC (2016), "Evidence-based Treatment Options in Cannabis Dependency"
- Journal of Clinical Investigation (2024), "Cannabis use disorder: from neurobiology to treatment"
- PMC (2016), "Treatment of Cannabis Use Disorder: Current Science and Future Outlook"
- PMC (2021), "Interventions for cannabis use disorder"
- Cannabis Evidence, "Treatments for Cannabis Use Disorder"
- Cleveland Clinic, "Cannabis Use Disorder: Treatment"
For evidence-based cannabis education, visit our companion site TryCannabis.org